Baek In-Cheol, Choi Eun-Jeong, Kim Hyoung-Jae, Choi Haeyoun, Shin Hyoung-Shik, Lim Dong-Gyun, Kim Tai-Gyu
Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
J Clin Med. 2024 Jan 2;13(1):258. doi: 10.3390/jcm13010258.
Middle East respiratory syndrome (MERS) is a lower respiratory tract disease caused by a beta coronavirus (CoV) called MERS-CoV, characterized by a high mortality rate. We aimed to evaluate the association between genetic variation in killer cell immunoglobulin-like receptors (KIRs) and the risk of MERS in South Koreans.
KIR genes were genotyped by multiplex polymerase chain reaction with sequence-specific primers (PCR-SSP). A case-control study was performed to identify the odds ratios (OR) of KIR genes for MERS and the association of KIR genes and their ligands, human leukocyte antigens (HLA) genes.
KIR2DS4D and KIR3DP1F showed higher frequencies in the group of all patients infected with MERS-CoV than in the control group ( = 0.023, OR = 2.4; = 0.039, OR = 2.7). KIR2DL1, KIR2DP1, and KIR3DP1D were significantly associated with moderate/mild (Mo/Mi) cases. KIR2DL2, KIR2DS1, and KIR3DP1F were affected in severe cases. When we investigated the association between KIR genes and their ligands in MERS patient and control groups, KIR3DL1+/Bw4(80I)+, KIR3DL1+/Bw6+, KIR3DL1+/Bw6-, KIR2DS1+/C2+, and KIR3DS+/Bw4(80I)+ were associated with MERS. KIR3DL1+/Bw6- was found in Mo/Mi cases. KIR2DS1+/C2+ and KIR2DS2+/C1+ were found in severe cases.
Further investigations are needed to prove the various immune responses of MERS-CoV-infected cells according to variations in the KIR gene and ligand gene. A treatment strategy based on current research on the KIR gene and MERS-CoV will suggest potential treatment targets.
中东呼吸综合征(MERS)是一种由名为MERS-CoV的β冠状病毒引起的下呼吸道疾病,其特征是死亡率高。我们旨在评估杀伤细胞免疫球蛋白样受体(KIRs)基因变异与韩国人患MERS风险之间的关联。
采用序列特异性引物多重聚合酶链反应(PCR-SSP)对KIR基因进行基因分型。进行病例对照研究以确定KIR基因对MERS的比值比(OR)以及KIR基因与其配体人类白细胞抗原(HLA)基因的关联。
KIR2DS4D和KIR3DP1F在所有感染MERS-CoV的患者组中的频率高于对照组(P = 0.023,OR = 2.4;P = 0.039,OR = 2.7)。KIR2DL1、KIR2DP1和KIR3DP1D与中度/轻度(Mo/Mi)病例显著相关。KIR2DL2、KIR2DS1和KIR3DP1F在重症病例中受到影响。当我们研究MERS患者组和对照组中KIR基因与其配体之间的关联时,KIR3DL1+/Bw4(80I)+、KIR3DL1+/Bw6+、KIR3DL1+/Bw6-、KIR2DS1+/C2+和KIR3DS+/Bw4(80I)+与MERS相关。在Mo/Mi病例中发现KIR3DL1+/Bw6-。在重症病例中发现KIR2DS1+/C2+和KIR2DS2+/C1+。
需要进一步研究以根据KIR基因和配体基因的变异来证明MERS-CoV感染细胞的各种免疫反应。基于当前对KIR基因和MERS-CoV的研究的治疗策略将提示潜在的治疗靶点。